Cargando…

Sepsis-induced Coagulopathy Subphenotype Identification by Latent Class Analysis

BACKGROUND: Recent studies have shown that anticoagulant therapy has heterogeneous treatment effects on patients with sepsis-induced coagulopathy (SIC). AIMS: To identify the latent phenotypes of patients with SIC. STUDY DESIGN: Retrospective cohort study. METHODS: We obtained data of patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Dan, Greco, Massimiliano, Wu, Qin, Cheng, Yisong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339839/
https://www.ncbi.nlm.nih.gov/pubmed/37265179
http://dx.doi.org/10.4274/balkanmedj.galenos.2023.2023-4-6
_version_ 1785071934752423936
author Cai, Dan
Greco, Massimiliano
Wu, Qin
Cheng, Yisong
author_facet Cai, Dan
Greco, Massimiliano
Wu, Qin
Cheng, Yisong
author_sort Cai, Dan
collection PubMed
description BACKGROUND: Recent studies have shown that anticoagulant therapy has heterogeneous treatment effects on patients with sepsis-induced coagulopathy (SIC). AIMS: To identify the latent phenotypes of patients with SIC. STUDY DESIGN: Retrospective cohort study. METHODS: We obtained data of patients with SIC from the Medical Information Mart for Intensive Care IV database. SIC subphenotypes were identified by latent class analysis (LCA) and K-means clustering. Clinical and laboratory variables were obtained in patients who met the diagnostic criteria for SIC. The baseline characteristics of the patients and the association between the heterogeneity of anticoagulant therapy and clinical outcomes (28-day and in-hospital mortality) were compared between the subphenotypes. RESULTS: We identified 4,993 patients with SIC. The LCA and K-means clustering analysis robustly identified three subphenotypes of SIC. Class 1 patients (n = 1,808) had the lowest blood cell counts (leukocytes, erythrocytes, and platelets). Class 2 patients (n = 1,157) had severe coagulopathy with a high prothrombin time and international normalized ratio, multiple-organ dysfunction, high lactate, sequential organ failure assessment score, and mortality. Class 3 (n = 2,028) were older, had more comorbidities, a higher fibrinogen concentration, and lower plasma and platelet infusion rates. After variable adjustments, heparin therapy reduced the 28-day mortality (odds ratio [OR] 0.39, 0.30-0.49, p < 0.001) and in-hospital mortality (OR 0.42, 0.33-0.53, p < 0.001) only in class 2. CONCLUSION: Three SIC subphenotypes were defined using clinical findings and laboratory variables. The effects of heparin treatment differ between the subphenotypes. This finding will facilitate the identification of target patients with SIC who should receive anticoagulant therapy.
format Online
Article
Text
id pubmed-10339839
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Galenos Publishing
record_format MEDLINE/PubMed
spelling pubmed-103398392023-07-14 Sepsis-induced Coagulopathy Subphenotype Identification by Latent Class Analysis Cai, Dan Greco, Massimiliano Wu, Qin Cheng, Yisong Balkan Med J Original Article BACKGROUND: Recent studies have shown that anticoagulant therapy has heterogeneous treatment effects on patients with sepsis-induced coagulopathy (SIC). AIMS: To identify the latent phenotypes of patients with SIC. STUDY DESIGN: Retrospective cohort study. METHODS: We obtained data of patients with SIC from the Medical Information Mart for Intensive Care IV database. SIC subphenotypes were identified by latent class analysis (LCA) and K-means clustering. Clinical and laboratory variables were obtained in patients who met the diagnostic criteria for SIC. The baseline characteristics of the patients and the association between the heterogeneity of anticoagulant therapy and clinical outcomes (28-day and in-hospital mortality) were compared between the subphenotypes. RESULTS: We identified 4,993 patients with SIC. The LCA and K-means clustering analysis robustly identified three subphenotypes of SIC. Class 1 patients (n = 1,808) had the lowest blood cell counts (leukocytes, erythrocytes, and platelets). Class 2 patients (n = 1,157) had severe coagulopathy with a high prothrombin time and international normalized ratio, multiple-organ dysfunction, high lactate, sequential organ failure assessment score, and mortality. Class 3 (n = 2,028) were older, had more comorbidities, a higher fibrinogen concentration, and lower plasma and platelet infusion rates. After variable adjustments, heparin therapy reduced the 28-day mortality (odds ratio [OR] 0.39, 0.30-0.49, p < 0.001) and in-hospital mortality (OR 0.42, 0.33-0.53, p < 0.001) only in class 2. CONCLUSION: Three SIC subphenotypes were defined using clinical findings and laboratory variables. The effects of heparin treatment differ between the subphenotypes. This finding will facilitate the identification of target patients with SIC who should receive anticoagulant therapy. Galenos Publishing 2023-07-12 /pmc/articles/PMC10339839/ /pubmed/37265179 http://dx.doi.org/10.4274/balkanmedj.galenos.2023.2023-4-6 Text en ©Copyright 2023 by Trakya University Faculty of Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/The Balkan Medical Journal published by Galenos Publishing House.
spellingShingle Original Article
Cai, Dan
Greco, Massimiliano
Wu, Qin
Cheng, Yisong
Sepsis-induced Coagulopathy Subphenotype Identification by Latent Class Analysis
title Sepsis-induced Coagulopathy Subphenotype Identification by Latent Class Analysis
title_full Sepsis-induced Coagulopathy Subphenotype Identification by Latent Class Analysis
title_fullStr Sepsis-induced Coagulopathy Subphenotype Identification by Latent Class Analysis
title_full_unstemmed Sepsis-induced Coagulopathy Subphenotype Identification by Latent Class Analysis
title_short Sepsis-induced Coagulopathy Subphenotype Identification by Latent Class Analysis
title_sort sepsis-induced coagulopathy subphenotype identification by latent class analysis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339839/
https://www.ncbi.nlm.nih.gov/pubmed/37265179
http://dx.doi.org/10.4274/balkanmedj.galenos.2023.2023-4-6
work_keys_str_mv AT caidan sepsisinducedcoagulopathysubphenotypeidentificationbylatentclassanalysis
AT grecomassimiliano sepsisinducedcoagulopathysubphenotypeidentificationbylatentclassanalysis
AT wuqin sepsisinducedcoagulopathysubphenotypeidentificationbylatentclassanalysis
AT chengyisong sepsisinducedcoagulopathysubphenotypeidentificationbylatentclassanalysis